ENT Updates

Short Communication

Relationship between Carotid Body Tumor and Thyroid Papillary Cancer

Downloads

Demirag Evman, M., & Atalay Erdogan, B. (2025). Relationship between Carotid Body Tumor and Thyroid Papillary Cancer. ENT Updates, 15(1). https://doi.org/10.54963/entu.v15i1.889

Authors

Carotid body tumor (CBT) represents a specific type of head and neck paraganglioma that is characteristically located at the bifurcation of the carotid artery. This tumor typically causes a separation of the external and internal carotid arteries. On the other hand, papillary thyroid carcinoma is recognized as the most common malignant neoplasm of the thyroid gland. In spite of the fact that they are distinctive pathologies, they both affect the neck region. Given the exceptionally low incidence of carotid body tumors (CBTs), the occurrence of an additional malignancy—whether synchronous or metachronous—in the same patient is expected to be an extraordinarily rare phenomenon. Within the literature, a genetic and syndromic relationship between carotid body tumor and papillary thyroid carcinoma is not however known. We describe two cases that could provide valuable insights into the limited body of evidence concerning the potential relationship between these distinct pathologies. The simultaneous presence of carotid body tumor and papillary thyroid carcinoma in a single patient might either represent a coincidental finding or stem from an unidentified genetic mutation.

Keywords:

Carotid Body Tumor Thyroid Cancer Paraganglioma Thyroidectomy

References

  1. Bryant, J.P.; Wang, S.; Niazi, T. Carotid Body Tumor Microenvironment. Adv. Exp. Med. Biol. 2020, 1296, 151–162. DOI: https://doi.org/10.1007/978-3-030-59038-3_9
  2. Sarookhani, A.; Chegini, R. Carotid Body Tumor: Our Experience with 42 Patients and a Literature Review. Indian J. Otolaryngol. Head Neck Surg. 2022, 74, 279–286. DOI: https://doi.org/10.1007/s12070-021-02453-8
  3. Alfawaz, A.A.; Albloushi, D., Quttaineh, D., et al. Malignant carotid body tumor: a report of two cases. Ann. Med. Surg. (Lond.) 2023, 85, 1857–1862. Doi: https://doi.org/10.1097/MS9.0000000000000402.
  4. Lam, A.K. Papillary Thyroid Carcinoma: Current Positionin Epidemiology, Genomics, and 221 Classification. Methods Mol. Biol. 2022, 2534, 1–15. DOI: https://doi.org/10.1007/978-1-0716-2505-7_1
  5. Erickson, D.; Kudva, Y.C.; Ebersold, M.J.; et al. Benign Paragang liomas: Clinical Presentation and Treatment Outcomes in 236 Patients. J. Clin. Endocrinol. Metab. 2001, 86, 5210–5216. DOI: https://doi.org/10.1210/jcem.86.11.8034
  6. Moskovic, D.J.; Smolarz, J.R.; Stanley, D.; et al. Malignant Head and Neck Paragangliomas: Is Therean Optimal Treatment Strategy? Head Neck Oncol. 2010, 23, 2–23. DOI: https://doi.org/10.1186/1758-3284-2-23
  7. Papaspyrou, K.; Mewes, T.; Rossmann, H.; et al. Head and Neck Paragangliomas: Report of 175 Patients (1989–2010). Head Neck 2012, 34, 632–637. DOI: https://doi.org/10.1002/hed.21790
  8. Bugalho, M.J.; Silva, A.L.; Domingues, R. Coexistence of Paraganglioma/Pheochromocytoma and Papillary Thyroid Carcinoma: A Four-Case Series Analysis. Fam. Cancer 2015, 14, 603–607. DOI: https://doi.org/10.1007/s10689-015-9818-8
  9. Kilic, Y.; Jalalzai, I.; Sönmez, E.; et al. The Surgical Treatment of Carotid Body Tumor as well as the Prevention and Management of Complications. Cureus 2024, 16, e51807. DOI: https://doi.org/10.7759/cureus.51807
  10. Kummer, W.; Yamamoto, Y. Cellular Distribution of Oxygen Sensor Candidates-Oxidases, Cytochromes, K+-Channels--in the Carotid Body. Microsc. Res. Tech. 2002, 59, 234–242. DOI: https://doi.org/10.1002/jemt.10197
  11. Dixon, J.L.; Atkins, M.D.; Bohannon, W.T.; et al. Surgical Management of Carotid Body Tumors: A 15-Year Single Institution Experience Employing an Interdisciplinary Approach. Proc. (Bayl. Univ. Med. Cent.) 2016, 29, 16–20. DOI: https://doi.org/10.1080/08998280.2016.11929343
  12. Davila, V.J.; Chang, J.M.; Stone, W.M.; et al. Current Surgical Management of Carotid Body Tumors. J. Vasc. Surg. 2016, 64, 1703–1710. DOI: https://doi.org/10.1016/j.jvs.2016.05.076
  13. Lee, K.Y.; Oh, Y.W.; Noh, H.J.; et al. Extraadrenal Paragangliomas of the Body: Imaging features. Am. J. Roentgenol. 2016, 187, 492–504. DOI: https://doi.org/10.2214/AJR.05.0370
  14. Metheetrairut, C.; Chotikavanich, C.; Keskool, P.; et al. Carotid Body Tumor: A 25-Year 214 Experience. Eur. Arch. Otorhinolaryngol. 2016, 273, 2171–2179. DOI: https://doi.org/10.1007/s00405-015-3737-z
  15. Decker, R.A.; Peacock, M.L.; Watson, P. Hirschsprung Diseasein MEN2A: Increased Spectrum of RET Exon 10 Genotypes and Strong Genotype-Phenotype Correlation. Hum. Mol. Genet. 1998, 7, 129–134. DOI: https://doi.org/10.1093/hmg/7.1.129
  16. Hoang, V.T.; Trinh, C.T.; Lai, T.A.K.; et al. Carotid Body Tumor: A Case Report and Literature Review. J. Radiol. Case Rep. 2019, 13, 19–30. DOI: https://doi.org/10.3941/jrcr.v13i8.3681
  17. Luis, P.O.; Martinez, J.A.; Ayala, O.A. Carotid Body Tumor Associated with Papillary Thyroid Carcinoma. Am. J. Otolaryngol. Head Neck Surg. 2020, 3, 1089. Available from: https://www.remedypublications.com/open-access/carotid-body-tumor-associated-with-papillary-thyroid-carcinoma-5852.pdf